Publication | Closed Access

A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy

Anti-emetic EfficacyMedicineMetronomic TherapyPharmacologyDolasetron MesilatePharmacotherapyMetronomic ChemotherapyCancer TreatmentOncologyCancer ResearchIntravenous Doses